Synonyms: EC 3.2.1.45 | VPRIV®
velaglucerase alfa is an approved drug (FDA and EMA (2010))
Compound class:
Peptide
|
Post-translational Modification | |
Disulfide bridges locations: 4-16, 18-23 Glycosylation sites: Asn19, Asn59, Asn146, Asn270, Asn462 |